FDA Inspection 1070668 — Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc.
The FDA completed an inspection of Worldwide Clinical Trials Early Phase Servcies/Bioanalytical Sciences, Inc. on Aug 31, 2018 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 31, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Austin, TX (United States)
Additional Details
In Vivo Bioequivalence